(Q113888138)
Statements
A Phase 1, Open-label, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Single and Multiple Doses of Oral Administration of HS-10241 in Patients With Locally Advanced or Metastatic Solid Tumors Who Have Progressed Following Prior Therapy (English)
0 references
21 June 2019
0 references
31 December 2020
0 references
30
0 references
18 year
0 references
75 year
0 references